Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema

The aim of this study was to investigate whether bronchoalveolar lavage (BAL) and serum levels of proinflammatory cytokines discriminate between different entities of patients with acute respiratory failure. BAL and circulating concentrations of interleukin-6 (IL-6), interleukin-8 (IL-8) and tumour necrosis factor-alpha (TNF-alpha) were measured in 74 mechanically-ventilated patients and 17 healthy controls. Patients were classified as cardiogenic pulmonary oedema (CPO), acute respiratory distress syndrome (ARDS), primary severe pneumonia (PN) and a combined group (PN+ARDS). In all patients with ARDS and/or PN, markedly elevated BAL levels of IL-6 and IL-8 were detected, which were significantly greater than levels in CPO and healthy controls. Absolute quantities and time-course of these cytokines did not differentiate between the absence and presence of lung infection, or different categories of PN. Similarly, circulating IL-6 levels were comparably elevated in patients with ARDS and/or PN, whereas circulating IL-8 concentrations were inconsistently increased. TNF-alpha was rarely detected in BAL samples, but increased serum concentrations were measured in ARDS and/or PN patients. Bronchoalveolar lavage levels of interleukin-6 and interleukin-8, but not tumour necrosis factor-alpha, and serum concentrations of interleukin-6 are consistently elevated in acute respiratory distress syndrome and/or severe pneumonia, discriminating these entities from cardiogenic pulmonary oedema. Alveolar and systemic cytokine profiles do not differentiate between acute respiratory distress syndrome in the absence of lung infection and states of severe primary or secondary pneumonia, which evidently present with comparable local and systemic inflammatory sequelae.

This article has been cited by other articles:

				C. M. Luna, O. Sibila, C. Agusti, and A. Torres Animal models of ventilator-associated pneumonia Eur. Respir. J., January 1, 2009; 33(1): 182 - 188. [Abstract] [Full Text] [PDF]

				O. Sibila, C. M. Luna, C. Agusti, S. Baquero, S. Gando, J. R. Patron, J. G. Morato, R. Absi, N. Bassi, and A. Torres Effects of glucocorticoids in ventilated piglets with severe pneumonia Eur. Respir. J., October 1, 2008; 32(4): 1037 - 1046. [Abstract] [Full Text] [PDF]

				A. L. Lagan, G. J. Quinlan, S. Mumby, D. D. Melley, P. Goldstraw, G. J. Bellingan, M. R. Hill, D. Briggs, P. Pantelidis, R. M. du Bois, et al. Variation in Iron Homeostasis Genes Between Patients With ARDS and Healthy Control Subjects Chest, June 1, 2008; 133(6): 1302 - 1311. [Abstract] [Full Text] [PDF]

				K. Okazaki, M. Kondo, M. Kato, R. Kakinuma, A. Nishida, M. Noda, K. Taniguchi, and H. Kimura Serum Cytokine and Chemokine Profiles in Neonates With Meconium Aspiration Syndrome Pediatrics, April 1, 2008; 121(4): e748 - e753. [Abstract] [Full Text] [PDF]

				R. A. Oeckler and R. D. Hubmayr Ventilator-associated lung injury: a search for better therapeutic targets Eur. Respir. J., December 1, 2007; 30(6): 1216 - 1226. [Abstract] [Full Text] [PDF]

				O. Sibila, C. Agusti, A. Torres, S. Baquero, S. Gando, J. R. Patron, J. G. Morato, D. H. Goffredo, N. Bassi, and C. M. Luna Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response Eur. Respir. J., December 1, 2007; 30(6): 1167 - 1172. [Abstract] [Full Text] [PDF]

				Z. Thomas and G. L Fraser An Update on the Diagnosis of Adrenal Insufficiency and the Use of Corticotherapy in Critical Illness Ann. Pharmacother., September 1, 2007; 41(9): 1456 - 1465. [Abstract] [Full Text] [PDF]

				S. K Gorman, R. S Slavik, and J. Marin Corticosteroid Treatment of Severe Community-Acquired Pneumonia Ann. Pharmacother., July 1, 2007; 41(7): 1233 - 1237. [Abstract] [Full Text] [PDF]

				D.-s. Cheng, W. Han, S. M. Chen, T. P. Sherrill, M. Chont, G.-Y. Park, J. R. Sheller, V. V. Polosukhin, J. W. Christman, F. E. Yull, et al. Airway Epithelium Controls Lung Inflammation and Injury through the NF-{kappa}B Pathway J. Immunol., May 15, 2007; 178(10): 6504 - 6513. [Abstract] [Full Text] [PDF]

				M. Maggiorini High altitude-induced pulmonary oedema Cardiovasc Res, October 1, 2006; 72(1): 41 - 50. [Abstract] [Full Text] [PDF]

				M E Callister, A Burke-Gaffney, G J Quinlan, A G Nicholson, R Florio, H Nakamura, J Yodoi, and T W Evans Extracellular thioredoxin levels are increased in patients with acute lung injury Thorax, June 1, 2006; 61(6): 521 - 527. [Abstract] [Full Text] [PDF]

				M. B. Everhart, W. Han, T. P. Sherrill, M. Arutiunov, V. V. Polosukhin, J. R. Burke, R. T. Sadikot, J. W. Christman, F. E. Yull, and T. S. Blackwell Duration and Intensity of NF-{kappa}B Activity Determine the Severity of Endotoxin-Induced Acute Lung Injury. J. Immunol., April 15, 2006; 176(8): 4995 - 5005. [Abstract] [Full Text] [PDF]

				T. Schilling, A. Kozian, C. Huth, F. Buhling, M. Kretzschmar, T. Welte, and T. Hachenberg The Pulmonary Immune Effects of Mechanical Ventilation in Patients Undergoing Thoracic Surgery Anesth. Analg., October 1, 2005; 101(4): 957 - 965. [Abstract] [Full Text] [PDF]

				P. Bartsch, H. Mairbaurl, M. Maggiorini, and E. R. Swenson Physiological aspects of high-altitude pulmonary edema J Appl Physiol, March 1, 2005; 98(3): 1101 - 1110. [Abstract] [Full Text] [PDF]

				S. P.M. Janssen, G. Gayan-Ramirez, A. Van Den Bergh, P. Herijgers, K. Maes, E. Verbeken, and M. Decramer Interleukin-6 Causes Myocardial Failure and Skeletal Muscle Atrophy in Rats Circulation, March 1, 2005; 111(8): 996 - 1005. [Abstract] [Full Text] [PDF]

				M. Confalonieri, R. Urbino, A. Potena, M. Piattella, P. Parigi, G. Puccio, R. Della Porta, C. Giorgio, F. Blasi, R. Umberger, et al. Hydrocortisone Infusion for Severe Community-acquired Pneumonia: A Preliminary Randomized Study Am. J. Respir. Crit. Care Med., February 1, 2005; 171(3): 242 - 248. [Abstract] [Full Text] [PDF]

				H. Kida, M. Yoshida, S. Hoshino, K. Inoue, Y. Yano, M. Yanagita, T. Kumagai, T. Osaki, I. Tachibana, Y. Saeki, et al. Protective effect of IL-6 on alveolar epithelial cell death induced by hydrogen peroxide Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L342 - L349. [Abstract] [Full Text] [PDF]

				P. Puneet, S. Moochhala, and M. Bhatia Chemokines in acute respiratory distress syndrome Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L3 - L15. [Abstract] [Full Text] [PDF]

				M. Kotani, T. Kotani, Z. Li, R. Silbajoris, C.A. Piantadosi, and Y-C.T. Huang Reduced inspiratory flow attenuates IL-8 release and MAPK activation of lung overstretch Eur. Respir. J., August 1, 2004; 24(2): 238 - 246. [Abstract] [Full Text] [PDF]

				Y. Zhang, J. Li, Y. Zhan, L. Wu, X. Yu, W. Zhang, L. Ye, S. Xu, R. Sun, Y. Wang, et al. Analysis of Serum Cytokines in Patients with Severe Acute Respiratory Syndrome Infect. Immun., August 1, 2004; 72(8): 4410 - 4415. [Abstract] [Full Text] [PDF]

				S. Fernandez-Serrano, J. Dorca, M. Coromines, J. Carratala, F. Gudiol, and F. Manresa Molecular Inflammatory Responses Measured in Blood of Patients with Severe Community-Acquired Pneumonia Clin. Vaccine Immunol., September 1, 2003; 10(5): 813 - 820. [Abstract] [Full Text] [PDF]

				P. Pelosi, D. D'Onofrio, D. Chiumello, S. Paolo, G. Chiara, V.L. Capelozzi, C.S.V. Barbas, M. Chiaranda, and L. Gattinoni Pulmonary and extrapulmonary acute respiratory distress syndrome are different Eur. Respir. J., August 1, 2003; 22(42_suppl): 48s - 56s. [Abstract] [Full Text] [PDF]

				S. V. Baudouin Lung injury after thoracotomy Br. J. Anaesth., July 1, 2003; 91(1): 132 - 142. [Full Text] [PDF]

				E. Papakonstantinou, M. Roth, M. Tamm, O. Eickelberg, A. P. Perruchoud, and G. Karakiulakis Hypoxia Differentially Enhances the Effects of Transforming Growth Factor-beta Isoforms on the Synthesis and Secretion of Glycosaminoglycans by Human Lung Fibroblasts J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 830 - 837. [Abstract] [Full Text] [PDF]

				E. R. Swenson, M. Maggiorini, S. Mongovin, J. S. R. Gibbs, I. Greve, H. Mairbaurl, and P. Bartsch Pathogenesis of High-Altitude Pulmonary Edema: Inflammation Is Not an Etiologic Factor JAMA, May 1, 2002; 287(17): 2228 - 2235. [Abstract] [Full Text] [PDF]

				W. Y. PARK, R. B. GOODMAN, K. P. STEINBERG, J. T. RUZINSKI, F. RADELLA II, D. R. PARK, J. PUGIN, S. J. SKERRETT, L. D. HUDSON, and T. R. MARTIN Cytokine Balance in the Lungs of Patients with Acute Respiratory Distress Syndrome Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1896 - 1903. [Abstract] [Full Text] [PDF]

				M. Maggiorini, C. Melot, S. Pierre, F. Pfeiffer, I. Greve, C. Sartori, M. Lepori, M. Hauser, U. Scherrer, and R. Naeije High-Altitude Pulmonary Edema Is Initially Caused by an Increase in Capillary Pressure Circulation, April 24, 2001; 103(16): 2078 - 2083. [Abstract] [Full Text] [PDF]

				U. Warrior, Y. Fan, C. A. David, J. A. Wilkins, E. M. McKeegan, J. L. Kofron, and D. J. Burns Application of QuantiGeneTM Nucleic Acid Quantification Technology for High Throughput Screening J Biomol Screen, October 1, 2000; 5(5): 343 - 351. [Abstract] [PDF]

				S. Rosseau, P. Hammerl, U. Maus, H.-D. Walmrath, H. Schutte, F. Grimminger, W. Seeger, and J. Lohmeyer Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome Am J Physiol Lung Cell Mol Physiol, July 1, 2000; 279(1): L25 - L35. [Abstract] [Full Text] [PDF]

				B. L. Weller, H. Witschi, and K. E. Pinkerton Quantitation and Localization of Pulmonary Manganese Superoxide Dismutase and Tumor Necrosis Factor {alpha} following Exposure to Ozone and Nitrogen Dioxide Toxicol. Sci., April 1, 2000; 54(2): 452 - 461. [Abstract] [Full Text] [PDF]

				T. T Bauer, C. Montón, A. Torres, H. Cabello, X. Fillela, A. Maldonado, J.-M. Nicolás, and E. Zavala Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls Thorax, January 1, 2000; 55(1): 46 - 52. [Abstract] [Full Text]

				M. H. Ali, S. A. Schlidt, N. S. Chandel, K. L. Hynes, P. T. Schumacker, and B. L. Gewertz Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction Am J Physiol Lung Cell Mol Physiol, November 1, 1999; 277(5): L1057 - L1065. [Abstract] [Full Text] [PDF]

				N. Hagimoto, K. Kuwano, M. Kawasaki, M. Yoshimi, Y. Kaneko, R. Kunitake, T. Maeyama, T. Tanaka, and N. Hara Induction of Interleukin-8 Secretion and Apoptosis in Bronchiolar Epithelial Cells by Fas Ligation Am. J. Respir. Cell Mol. Biol., September 1, 1999; 21(3): 436 - 445. [Abstract] [Full Text]

				E. R. Goodman, E. Kleinstein, A. M. Fusco, D. P. Quinlan, R. Lavery, D. H. Livingston, E. A. Deitch, and C. J. Hauser Role of Interleukin 8 in the Genesis of Acute Respiratory Distress Syndrome Through an Effect on Neutrophil Apoptosis Arch Surg, November 1, 1998; 133(11): 1234 - 1239. [Abstract] [Full Text] [PDF]

				M. Tamm, M. Bihl, O. Eickelberg, P. Stulz, A. P. Perruchoud, and M. Roth Hypoxia-Induced Interleukin-6 and Interleukin-8 Production Is Mediated by Platelet-Activating Factor and Platelet-Derived Growth Factor in Primary Human Lung Cells Am. J. Respir. Cell Mol. Biol., October 1, 1998; 19(4): 653 - 661. [Abstract] [Full Text]

				M. LEVI, T. van der POLL, H. ten CATE, B. KUIPERS, B. J. BIEMOND, H. M. JANSEN, and J. W. ten CATE Differential Effects of Anti-cytokine Treatment on Bronchoalveolar Hemostasis in Endotoxemic Chimpanzees Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 92 - 98. [Abstract] [Full Text] [PDF]